Endocrinology and Metabolism

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Clinical Outcomes of N1b Papillary Thyroid Cancer Patients Treated with Two Different Doses of Radioiodine Ablation Therapy

Meihua Jin, Jonghwa Ahn, Yu-Mi Lee, Tae-Yon Sung, Won Gu Kim, Tae Yong Kim, Jin-Sook Ryu, Won Bae Kim, Young Kee Shong, Min Ji Jeon

Endocrinol Metab. 2020;35(3):602-609. Published online September 22, 2020
DOI: https://doi.org/10.3803/EnM.2020.741

Clinical Outcomes of N1b Papillary Thyroid Cancer Patients Treated with Two Different Doses of Radioiodine Ablation Therapy

Meihua Jin, Jonghwa Ahn, Yu-Mi Lee, Tae-Yon Sung, Won Gu Kim, Tae Yong Kim, Jin-Sook Ryu, Won Bae Kim, Young Kee Shong, Min Ji Jeon

Endocrinology and Metabolism. 2020;35(3):602-609

Link1

Link2 Link3

Response to Tulchinsky and Avram re: “Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 Millicurie Radioiodine”

Muhammad Mujammami, Michael Tamilia

Thyroid. 2017;27(4):592-592

Link1 Link2

Unfavorable Responses to Radioiodine Therapy in N1b Papillary Thyroid Cancer: A Propensity Score Matching Study

Yan-Qing Liu, Hui Li, Jie-Rui Liu, Yan-Song Lin

Endocrine Practice. 2019;25(12):1286-1294

Link1 Link2

Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 milliCuries Radioiodine

Muhammad Mujammami, Michael P. Hier, Richard J. Payne, Louise Rochon, Michael Tamilia

Thyroid. 2016;26(7):951-958

Link1 Link2

Clinical outcomes of patients with T4 or N1b well-differentiated thyroid cancer after different strategies of adjuvant radioiodine therapy

Shin Young Jeong, Sang-Woo Lee, Wan Wook Kim, Jin Hyang Jung, Won Kee Lee, Byeong-Cheol Ahn, Jaetae Lee

Scientific Reports. 2019;9(1):

Link1

Link2 Link3

Re: “Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 Millicurie Radioiodine” by Mujammami et al. (Thyroid 2016;26:951–958): Patient Cohort Definition Makes No Sense

Mark Tulchinsky, Anca M. Avram

Thyroid. 2017;27(4):591-591

Link1 Link2

Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases

Christine J. O'Neill, Nicholas Coorough, James C. Lee, Joshua Clements, Leigh W. Delbridge, Rebecca Sippel, Mark S. Sywak, Herb Chen, Stan B. Sidhu

ANZ Journal of Surgery. 2013;84(4):240-244

Link1 Link2

Health outcomes of children fathered by patients treated with radioiodine for thyroid cancer

Jérôme-Philippe Garsi, Martin Schlumberger, Marcel Ricard, Martine Labbé, Claudia Ceccarelli, Claire Schvartz, Michel Henry-Amar, Stéphane Bardet, Carole Rubino, Florent De Vathaire

Clinical Endocrinology. 2009;71(6):880-883

Link1 Link2

Radioiodine Ablation for Differentiated Thyroid Cancer—None, One Dose or Two?

G.J.G. Rees

Clinical Oncology. 2010;22(2):131-135

Link1 Link2

Outcomes of Thyrotropin Alfa Versus Levothyroxine Withdrawal-Aided Radioiodine Therapy for Distant Metastasis of Papillary Thyroid Cancer

Joana Simões-Pereira, Teresa C. Ferreira, Edward Limbert, Branca Maria Cavaco, Valeriano Leite

Thyroid. 2021;

Link1 Link2